• LAST PRICE
    1.3108
  • TODAY'S CHANGE (%)
    Trending Down-0.0892 (-6.3714%)
  • Bid / Lots
    1.3100/ 1
  • Ask / Lots
    1.3200/ 1
  • Open / Previous Close
    1.3500 / 1.4000
  • Day Range
    Low 1.2400
    High 1.4200
  • 52 Week Range
    Low 1.1400
    High 6.0000
  • Volume
    38,048
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.4
TimeVolumeHSCS
09:32 ET1101.35
09:48 ET20001.36
09:50 ET5001.36
09:55 ET1001.36
10:00 ET21521.3133
10:02 ET25001.3999
10:15 ET20001.3141
10:24 ET25001.3999
10:36 ET1001.4
10:47 ET19501.3644
11:00 ET20001.42
11:16 ET2001.38
11:27 ET1001.41
11:34 ET33411.35
11:43 ET1861.3454
11:50 ET1001.37
12:15 ET10001.3485
12:51 ET1001.32
12:53 ET21911.32
01:00 ET3001.33
01:04 ET48951.27
01:09 ET3001.305
01:13 ET60961.2905
01:15 ET7001.33
01:22 ET1791.3245
01:29 ET4001.31
02:12 ET4601.2927
02:25 ET1001.32
02:30 ET2001.3108
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesHSCS
Heart Test Laboratories Inc
11.5M
-1.9x
---
United StatesIINN
Inspira Technologies Oxy BHN Ltd
11.1M
-0.5x
---
United StatesRMED
Ra Medical Systems Inc
10.5M
0.0x
---
United StatesNNMX
Nanomix Corp
12.1M
-0.4x
---
United StatesBRSF
Brain Scientific Inc
12.2M
-0.4x
---
United StatesCSOC
Caduceus Software Systems Corp
8.6M
-35.0x
---
As of 2022-12-08

Company Information

Heart Test Laboratories, Inc. is a medical technology company focused on developing artificial intelligence (AI) based technology to an electrocardiogram (ECG) to expand and improve an ECG’s clinical usefulness. The Company’s product candidate, the MyoVista wavECG, or the MyoVista, is designed to provide diagnostic information related to cardiac dysfunction. The MyoVista is a 12-lead resting ECG device that features its algorithm developed to detect cardiac dysfunction in the diastolic phase, specifically slower than normal left ventricular relaxation rates. The MyoVista uses electrical information from the heart captured during a standard resting 12-lead ECG test as inputs to an artificial intelligence-based algorithm. The MyoVista detects whether a patient is negative or positive for abnormally slow left ventricular diastolic relaxation rates.

Contact Information

Headquarters
550 Reserve St, Suite 360SOUTHLAKE, TX, United States 76092
Phone
682-237-7781
Fax
---

Executives

Chairman of the Board, President, Chief Executive Officer
Andrew Simpson
Chief Financial Officer, Treasurer
Danielle Watson
Chief Operating Officer, Secretary, Director
Mark Hilz
Independent Director
Bruce Bent
Independent Director
Patrick Kanouff

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$11.5M
Revenue (TTM)
$10.1K
Shares Outstanding
8.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.71
Book Value
$-0.74
P/E Ratio
-1.9x
Price/Sales (TTM)
1,138.1
Price/Cash Flow (TTM)
---
Operating Margin
-54,163.03%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.